HELSINN BIREX THERAPEUTICS
HELSINN BIREX THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1985-01-01
Address:
Dublin, Dublin, Ireland
Country:
Ireland
Status:
Active
Contact:
+353 1 822 5417
More informations about "Helsinn Birex Therapeutics"
Our Story - Helsinn
A pivotal moment occurred in 2009, when Helsinn acquired Sapphire Therapeutics, which later became Helsinn Therapeutics US. This acquisition expanded our portfolio and strengthened …See details»
Locations - Helsinn
Helsinn is headquartered in Lugano, Switzerland. The company has a global presence with a 360° approach of quality, state-of-the-art R&D and world-class production facilities at Helsinn Birex Pharmaceuticals Ltd., in Ireland and a …See details»
Helsinn Birex Therapeutics - Crunchbase
Helsinn Birex Therapeutics markets and sells pharmaceutical products.See details»
Helsinn Birex Therapeutics Ltd.: Drug pipelines, Patents, Clinical ...
Explore Helsinn Birex Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Helsinn Launches Fully Integrated Targeted Therapy (FITT) …
Jan 14, 2022 Helsinn is a fully integrated, global biopharma company headquartered in Lugano, Switzerland. It is focused on improving the lives of cancer patients all over the world with a …See details»
Helsinn Birex Pharmaceuticals - Crunchbase
Helsinn Birex Pharmaceuticals closed its last funding round on May 24, 2018 from a Venture - Series Unknown round. Who are Helsinn Birex Pharmaceuticals's competitors? Alternatives and possible competitors to Helsinn Birex …See details»
Helsinn Launches FITT
Jan 13, 2022 Mr. Kaul will bring a wealth of expertise, a significant asset which will strengthen the organization. Riccardo Braglia, Helsinn Group Executive Chairman commented: “This is an …See details»
Helsinn Group and BridgeBio Update Collaboration | BridgeBio
Mar 3, 2022 Helsinn also has a fully integrated supply chain and product development through its subsidiary in Ireland, Helsinn Birex Pharmaceuticals Ltd. Helsinn Group plays an active and …See details»
Helsinn Birex Therapeutics - PitchBook
Information on acquisition, funding, investors, and executives for Helsinn Birex Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group ...
Mar 31, 2021 The Group has additional operating subsidiaries in Switzerland (Helsinn Advanced Synthesis, an active pharmaceutical ingredient manufacturer) and Ireland (Helsinn Birex …See details»
Helsinn Launches Fully Integrated Targeted Therapy (FITT)
Jan 13, 2022 Helsinn intends to continue to invest approximately 35 percent of its revenues from its commercial engine of supportive care and cancer therapeutics products into targeted …See details»
Helsinn Establishes New R&D Hub in the U.S. to Support its
May 25, 2022 Bringing this R&D expertise into HTU through this new hub complements the global R&D organization and is the next step in Helsinn’s strategy of creating a differentiated …See details»
Helsinn Launches Fully Integrated Targeted Therapy (FITT) …
Jan 13, 2022 Helsinn intends to continue to invest approximately 35 percent of its revenues from its commercial engine of supportive care and cancer therapeutics products into targeted …See details»
New R&D Hub in the U.S. | Helsinn
May 25, 2022 New R&D hub will be based at U.S. subsidiary, Helsinn Therapeutics (U.S.), Inc. (HTU) and will support clinical work across Helsinn Group’s diversified pipeline of innovative …See details»
Manufacturing and Supply - Helsinn
Internal product manufacturing and supply operations Helsinn Birex Pharmaceuticals, located close to Dublin, Ireland, spans an 8,000 square meters on a 27,000 square-meter area. The …See details»
Helsinn Group and BridgeBio Pharma Announce Update to …
Mar 3, 2022 Helsinn Group and BridgeBio Pharma Announce Update to Strategic Collaboration to Develop, Manufacture and Commercialize Infigratinib in Oncology Indications in the U.S. …See details»
Helsinn Group announces oral presentation of data at AACR-NCI …
Lugano, Switzerland, 7 October2021– Helsinn Group, a Swiss Biopharmaceutical Group with an innovative R&D pipeline in cancer supportive care and oncology therapeutics, strategically …See details»
Dublin, Ireland - Helsinn
Helsinn Birex Pharmaceuticals Ltd, established in Ireland in 1990, is our world-class manufacturing, packaging and release site developing oral solid dosage forms and a stability …See details»
Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics ...
Sep 29, 2021 Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics Announce Health Canada Conditional Approval of TRUSELTIQâ„¢ (infigratinib) for Patients with …See details»